Heartflow

HTFL · NASDAQ

$55.59+$4.57 (+8.96%)TodayMarket closed · Oct 20, 7:58 PM ET

Prev close $51.02

About HTFL

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The company is headquartered in Mountain View, California and currently employs 843 full-time employees. The company went IPO on 2025-08-08. The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Employees: 843
Headquarters: Mountain View, California
Listed: Aug 8, 2025
Sector: Health Care
Industry: Health Care Technology
Website: heartflow.com

Leadership

Heartflow executives
Name	Title	Since	Age
William Weldon	—	—	76
John Farquhar	—	2021	53
Vikram Verghese	—	—	41
Campbell Rogers	—	—	64
Nicholas Downing	—	—	40
Charles Taylor	—	—	61
Timothy Barabe	—	—	72
Julie Cullivan	—	—	59
Jeffrey Lightcap	—	—	66
Wayne Riley	—	—	66
Lonnie Smith	—	—	80
Casey Tansey	—	—	67

Similar companies

Companies in the same industry as Heartflow

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.